5913 Results

People

  1. Ladanyi
    Ladanyi
  2. Solit
    Solit
  3. Levine
    Levine
  4. Berger
    Berger
  5. Schultz
    Schultz
  6. Arcila
    Arcila
  7. Hakimi
    Hakimi
  8. Chandarlapaty
    Chandarlapaty
  9. Zehir
    Zehir
  10. Mellinghoff
    Mellinghoff

Groups

  1. Human Oncology and Pathogenesis Program (5913)
  2. GSK Faculty (5696)
  3. Department of Medicine (4258)
  4. Department of Pathology and Laboratory Medicine (3036)
  5. Tow Center for Developmental Oncology (TCDO) (2612)
  6. Solid Tumor Oncology Division (2599)
  7. Sloan Kettering Institute Postdocs (1984)
  8. Hematologic Malignancies, Division of (1879)
  9. Center for Hematologic Malignancies (1845)
  10. Center for Molecular Imaging and Biotechnology (CMIB) (1735)
  1. "Human Oncology and Pathogenesis Program"
Formats
  1. Journal Article (2984)
  2. Meeting Abstract (2526)
  3. Review (137)
  4. Editorial (106)
  5. Book Section (54)
  6. Research Letter (41)
  7. Guidelines (18)
  8. Correspondence (16)
  9. Miscellaneous (15)
  10. Conference Paper (13)
  11. Book Whole (3)
Groups
  1. Human Oncology and Pathogenesis Program (5913)
  2. GSK Faculty (5696)
  3. Department of Medicine (4258)
  4. Department of Pathology and Laboratory Medicine (3036)
  5. Tow Center for Developmental Oncology (TCDO) (2612)
  6. Solid Tumor Oncology Division (2599)

More Groups

People
  1. Marc Ladanyi (1326)
  2. David Solit (779)
  3. Ross Levine (774)
  4. Michael Berger (765)
  5. Nikolaus Schultz (486)
  6. Maria Arcila (426)

More People

Years
  1. 2025 (119)
  2. 2024 (359)
  3. 2023 (402)
  4. 2022 (451)
  5. 2021 (380)
  6. 2020 (457)

More Years

Publications
  1. Journal of Clinical Oncology (636)
  2. Blood (495)
  3. Cancer Research (412)
  4. Modern Pathology (299)
  5. Clinical Cancer Research (268)
  6. Laboratory Investigation (262)

More Publications

Publishers
  1. American Association for Cancer Research (871)
  2. Nature Publishing Group (757)
  3. American Society of Clinical Oncology (702)
  4. American Society of Hematology (541)
  5. Elsevier Inc. (420)
  6. Nature Research (312)

More Publishers

Results (5913)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Impact of concurrent PIK3CA mutations on response to EGFR tyrosine kinase inhibition in EGFR-mutant lung cancers and on prognosis in oncogene-driven lung adenocarcinomas
    Journal Article

    Eng, J.; Woo, K. M.; Sima, C. S.; Plodkowski, A.; Hellmann, M. D.; Chaft, J. E.; Kris, M. G.; Arcila, M. E.; Ladanyi, M.; Drilon, A.
    Journal of Thoracic Oncology (2015)

    Fulltext@MSK | Save
  • A quantitative system for studying metastasis using transparent zebrafish
    Journal Article

    Heilmann, S.; Ratnakumar, K.; Langdon, E. M.; Kansler, E. R.; Kim, I. S.; Campbell, N. R.; Perry, E. B.; McMahon, A. J.; Kaufman, C. K.; Van Rooijen, E.; more...
    Cancer Research (2015)

    Fulltext@MSK | Save
  • NF2 loss promotes oncogenic RAS-induced thyroid cancers via YAP-dependent transactivation of RAS proteins and sensitizes them to MEK inhibition
    Journal Article

    Garcia-Rendueles, M. E. R.; Ricarte-Filho, J. C.; Untch, B. R.; Landa, I.; Knauf, J. A.; Voza, F.; Smith, V. E.; Ganly, I.; Taylor, B. S.; Persaud, Y.; more...
    Cancer Discovery (2015)

    Fulltext@MSK | Save
  • EGFR kinase domain duplication (EGFR -KDD) is a novel oncogenic driver in lung cancer that is clinically responsive to afatinib
    Journal Article

    Gallant, J. N.; Sheehan, J. H.; Shaver, T. M.; Bailey, M.; Lipson, D.; Chandramohan, R.; Brewer, M. R.; York, S. J.; Kris, M. G.; Pietenpol, J. A.; more...
    Cancer Discovery (2015)

    Fulltext@MSK | Save
  • All the world’s a stage: Facilitating discovery science and improved cancer care through the Global Alliance for Genomics and Health
    Journal Article

    Lawler, M.; Siu, L. L.; Rehm, H. L.; Chanock, S. J.; Alterovitz, G.; Burn, J.; Calvo, F.; Lacombe, D.; Teh, B. T.; North, K. N.; more...
    Cancer Discovery (2015)

    Fulltext@MSK | Save
  • Ultrasmall dual-modality silica nanoparticle drug conjugates: Design, synthesis, and characterization
    Journal Article

    Yoo, B.; Ma, K.; Zhang, L.; Burns, A.; Sequeira, S.; Mellinghoff, I.; Brennan, C.; Wiesner, U.; Bradbury, M. S.
    Bioorganic & Medicinal Chemistry (2015)

    Fulltext@MSK | Save
  • Simulation in continuing education: Improving hematologist evidence-based decisions for myeloproliferative neoplasm management
    Meeting Abstract

    Van Laar, E.; Blevins, D.; Levine, R.; Mesa, R.
    Haematologica (2015)

    Fulltext@MSK | Save
  • Ag-221, an oral, selective, first-in-class, potent inhibitor of the IDH2 mutant enzyme, induced durable responses in a phase 1 study of IDH2 mutation-positive advanced hematologic malignancies
    Meeting Abstract

    DiNardo, C.; Stein, E. M.; Altman, J. K.; Collins, R.; DeAngelo, D. J.; Fathi, A. T.; Flinn, I.; Frankel, A.; Levine, R. L.; Medeiros, B. C.; more...
    Haematologica (2015)

    Fulltext@MSK | Save
  • DNMT3A R882 mutation promote chemoresistance and therapeutic relapse through impaired DNA-damage sensing
    Meeting Abstract

    Guryanova, O.; Shank, K.; Garrett-Bakelman, F.; Spitzer, B.; Ganzel, C.; Rapaport, F.; Keller, M.; Evangelista, L.; Glass, J.; Rowe, J.; more...
    Haematologica (2015)

    Fulltext@MSK | Save
  • Comprehensive analyses of oncogenic driver fusions using the NanoString nCounter in lung adenocarcinoma from Japanese never- and light-smokers
    Meeting Abstract

    Takamochi, K.; Suehara, Y.; Mogushi, K.; Kohsaka, S.; Mano, H.; Takeuchi, K.; Saito, T.; Suzuki, K.; Ladanyi, M.; Takahashi, K.; more...
    European Journal of Cancer (2015)

    Fulltext@MSK | Save